Profile

Cover photo
106 followers|13,432 views
AboutPostsPhotosYouTube

Stream

Global Health Progress

Shared publicly  - 
 
Merck, known as MSD outside the United States and Canada, applauds the government of Ecuador on being the second country in the world to receive +World Health Organization verification of the elimination of river blindness (onchocerciasis) using MECTIZAN® (ivermectin).

In October 1987, Merck announced it would donate the medication MECTIZAN to all who need it for as long as necessary until onchocerciasis is eliminated as a public health problem. The MECTIZAN Donation Program reaches more than 150 million people annually.

In Latin America, since 1989, more than 13 million treatments of donated MECTIZAN have been delivered by community health workers and non-governmental organizations.

http://www.mercknewsroom.com/news-release/corporate-news/merck-congratulates-ecuador-second-country-receive-pahowho-verification-
1
Add a comment...

Global Health Progress

Shared publicly  - 
 
River blindness causes severe itching and discomfort and eventual blindness among infected people. Forty years ago, this disease was rampant around Africa's rivers and lakes. Today, is it all but eradicated thanks to a partnership that has brought life-saving medicines to the areas where they are needed most.

Treating River Blindness and Other Neglected Tropical Diseases
1
Add a comment...

Global Health Progress

Shared publicly  - 
 
At the 67th World Health Assembly this week, Merck KGaA proposed the creation of a global alliance for the elimination of Schistosomiasis.

http://news.emdgroup.com/N/0/DDFC2D5F40C634A9C1257CDD004132A4/$File/WHAEMD.pdf
1
Add a comment...

Global Health Progress

Shared publicly  - 
 
Japanese drugmaker Eisai has launched a new Access to Medicines Navigator website to get proper medical treatments to patients who have no access due to inadequate medical services and supply systems.

The site explains the causes and symptoms, prevention methods and treatments for HIV/AIDS, malaria and tuberculosis, as well as the World Health Organization’s 17 high-priority neglected tropical diseases.

http://atm.eisai.co.jp/english/
The issue of ”Access to Medicines” is that proper medicines and medical treatments are unavailable to patients in need for reasons such as poverty and underdeveloped healthcare systems. Eisai is actively making efforts to resolve ATM issues. This website provides visitors with basic knowledge on ”Access to Medicines”, Neglected Tropical Diseases, as well as initiatives by Eisai and other organizations to overcome the problem.
1
Add a comment...
Have them in circles
106 people
Amber Windsor's profile photo
CORE Group's profile photo
Shama Kukkady's profile photo
RinGs Rpc's profile photo
Ward Health's profile photo
Drug Bot's profile photo
Mark Gillican's profile photo
Oluwagbemiga Abiola's profile photo
Blessilda Santos's profile photo

Global Health Progress

Shared publicly  - 
 
Join us tomorrow (June 10th) at 10am EDT for #NCDQA  - an hour-long online Q&A with Jeff Sturchio and Louis Galambos focused on the impact of noncommunicable diseases (NCDs) in the developing world.  Jeffrey L. Sturchio, Senior Partner at Rabin Martin and Louis Galambos, co-director of the Institute for Applied Economics, Global Health, and the Study of Business Enterprise at The Johns Hopkins University will be answering questions related to the impact of NCDs and addressing gaps in global policy and research.

Follow the discussion - proudly hosted by Global Health Progress and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) -  on June 10th on twitter using #NCDQA or visit the site to see full answers.

http://www.globalhealthprogress.org/qa/ncdsdevelopingworld
1
Add a comment...

Global Health Progress

Shared publicly  - 
 
"As we look toward the post-2015 sustainable development agenda, the imperatives of chronic disease call for immediate action from governments, NGOs, the private sector and multilateral agencies to implement pragmatic initiatives that focus on prevention, health system strengthening and intersect oral collaboration."

Pragmatic policies for addressing the challenge of NCDs - report by Jeffrey L. Sturchio and Louis Galambos

http://www.commonwealthhealth.org/wp-content/uploads/2014/05/5-challenge-of-NCD-sturchio.pdf
1
Add a comment...

Global Health Progress

Shared publicly  - 
 
Online Q&A with Jeff Sturchio and Louis Galambos
May 9, 2014.  10:00am - 11:00am, EDT
#NCDQA

Global Health Progress is proud to host an hour-long conversation focused on the impact of noncommunicable diseases (NCDs) in the developing world with Jeffrey L. Sturchio, Senior Partner at Rabin Martin and Louis Galambos, co-director of the Institute for Applied Economics, Global Health, and the Study of Business Enterprise at The Johns Hopkins University – co-editors of Noncommunicable Diseases in the Developing World:  Addressing Gaps in Global Policy and Research, published by Johns Hopkins University Press (2013).

We encourage those interested to submit questions in advance via the form on the Global Health Progress page or by sending a message to @GlobalHealth. 

Follow the discussion on May 9th on twitter using #NCDQA.

http://www.globalhealthprogress.org/qa/ncdsdevelopingworld
1
Add a comment...

Global Health Progress

Shared publicly  - 
1
Add a comment...
People
Have them in circles
106 people
Amber Windsor's profile photo
CORE Group's profile photo
Shama Kukkady's profile photo
RinGs Rpc's profile photo
Ward Health's profile photo
Drug Bot's profile photo
Mark Gillican's profile photo
Oluwagbemiga Abiola's profile photo
Blessilda Santos's profile photo
Story
Tagline
Global health initiative to improve access to medicines and healthcare